Physician profile
Sun Byun
NPI 1720510225
$367.14
in general payments reported to CMS, 2019-2025
10 companies · $90.85 in 2025
The $90.85 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.95 · 2022: $46.93 · 2023: $47.06 · 2024: $166 · 2025: $90.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $304.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $124.14 | 2024-2025 | Krystexxa |
| Averitas Pharma INC. | $47.06 | 2023 | Qutenza |
| Nevro Corp. | $36.91 | 2024 | Senza |
| Cashflow Solutions, LLC | $32.56 | 2024-2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Smith+Nephew, INC. | $26.81 | 2022 | |
| Globus Medical, INC. | $25.70 | 2025 | Senza |
| Paratek Pharmaceuticals, INC. | $22.96 | 2024 | Nuzyra |
| Depuy Synthes Sales INC. | $20.12 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.95 | 2020 | |
| Bioventus LLC | $14.93 | 2024 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sun Byun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.